Jung, H. A., Maeng, C. H., Kim, M., Kim, S., Jung, C. W., & Jang, J. H. (2015). Platelet response during the second cycle of decitabine treatment predicts response and survival for myelodysplastic syndrome patients. Oncotarget.

Jung, Hyun Ae, Chi Hoon Maeng, Moonjin Kim, Sungmin Kim, Chul Won Jung, و Jun Ho Jang. "Platelet Response During the Second Cycle of Decitabine Treatment Predicts Response and Survival for Myelodysplastic Syndrome Patients." Oncotarget 2015.

Jung, Hyun Ae, et al. "Platelet Response During the Second Cycle of Decitabine Treatment Predicts Response and Survival for Myelodysplastic Syndrome Patients." Oncotarget 2015.